This Sterne Kessler webinar will provide insights regarding significant aspects of post-grant proceedings at the Patent Trial and Appeal Board (PTAB) including:

• The institution rates and trial outcomes for these proceedings, which are largely driven by inter partes reviews (IPRs), and will include a review of the data from pharma and biotech industry IPRs;

• The importance of the post-grant proceeding petition, key considerations on which a patent challenger should focus when preparing its petition, and when and how a patent owner can and should respond to these key considerations; and

• An overview of post-grant proceedings on appeal and predictions for these proceedings in the pharma and biotech industry going forward.